Why the study?
Does the G allele of rs5068 within the NPPA locus reduce incident type 2 diabetes in individuals without known diabetes?
Does the G allele of rs5068 within the NPPA locus reduce incident type 2 diabetes in individuals without known diabetes?
The presence of the G allele of rs5068 in the NPPA locus is associated with a reduced risk of incident type 2 diabetes, suggesting a potential protective role of the atrial natriuretic peptide system in diabetes development.
Answers are grounded in this paper and cite their sources.
rs5068 G allele was associated with lower incident diabetes; leaves open whether NPPA variants causally influence type 2 diabetes risk.
BACKGROUND: We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. METHODS: We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmö Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). RESULTS: In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037). CONCLUSION: Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Jujić et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: